BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ballarin R, Cucchetti A, Russo FP, Magistri P, Cescon M, Cillo U, Burra P, Pinna AD, Di Benedetto F. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol 2017; 23(12): 2095-2105 [PMID: 28405138 DOI: 10.3748/wjg.v23.i12.2095]
URL: https://www.wjgnet.com/1948-5182/full/v23/i12/2095.htm
Number Citing Articles
1
Patrizia Burra, Didier Samuel, Vinay Sundaram, Christophe Duvoux, Henrik Petrowsky, Norah Terrault, Rajiv Jalan. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantationJournal of Hepatology 2021; 75: S178 doi: 10.1016/j.jhep.2021.01.007
2
Francesco Paolo Russo, Mauro Viganò, Peter Stock, Alberto Ferrarese, Nicola Pugliese, Patrizia Burra, Alessio Aghemo. HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologistJournal of Hepatology 2022; 77(2): 503 doi: 10.1016/j.jhep.2022.03.007
3
Niklas F. Aehling, Daniel Seehofer, Thomas Berg. Aktuelle Entwicklungen bei der Lebertransplantation – Wo stehen wir?DMW - Deutsche Medizinische Wochenschrift 2020; 145(16): 1124 doi: 10.1055/a-0982-0737
4
Philip Vutien, Mindie H. Nguyen. Expanding the Donor Pool for Liver Transplantation: Assessing the Potential Use of HBV-Positive AllograftsCurrent Hepatology Reports 2024;  doi: 10.1007/s11901-024-00653-8
5
Di Lu, Fan Yang, Jianyong Zhuo, Modan Yang, Zuyuan Lin, Pingbo Jin, Xuechun Cai, Beini Cen, Jianguo Wang, Xuyong Wei, Shusen Zheng, Xiao Xu. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular CarcinomaClinical and Translational Gastroenterology 2020; 11(5): e00168 doi: 10.14309/ctg.0000000000000168
6
Zhitao Chen, Yihao Ma, Yuqi Dong, Chuanbao Chen, Hanyu Wang, Tielong Wang, Jia Yu, Xitao Hong, Maogen Chen, Xiaoshun He, Weiqiang Ju. Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysisPeerJ 2023; 11: e15620 doi: 10.7717/peerj.15620
7
Afroditi Orfanidou, George V. Papatheodoridis, Evangelos Cholongitas. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current conceptsLiver International 2021; 41(7): 1448 doi: 10.1111/liv.14860
8
Amr Badawy, Toshimi Kaido, Shinji Uemoto. Current Status of Liver Transplantation Using Marginal GraftsJournal of Investigative Surgery 2020; 33(6): 553 doi: 10.1080/08941939.2018.1517197
9
Jiong Yu, Xiaowei Shi, Haiying Yu, Jian Wu, Jing Ma, Siyi Dong, Sen Lu, Shusen Zheng, Lanjuan Li, Xiao Xu, Hongcui Cao. Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver diseaseJournal of Medical Virology 2022; 94(7): 3338 doi: 10.1002/jmv.27703
10
Songfeng Yu, Chao Cen, Xuanyu Zhang, Longyu Cheng, Weiliang Xia, Junjun Jia, Yufu Ye, Jun Yu, Min Zhang, Yan Shen, Shusen Zheng. Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohortJournal of Gastroenterology and Hepatology 2022; 37(6): 1052 doi: 10.1111/jgh.15821